Cannabis as a source of approved drugs: A new look at an old problem

A Gabarin, L Yarmolinsky, A Budovsky, B Khalfin… - Molecules, 2023 - mdpi.com
Cannabis plants have been used in medicine since ancient times. They are well known for
their anti-diabetic, anti-inflammatory, neuroprotective, anti-cancer, anti-oxidative, anti …

Cannabidiol and brain function: current knowledge and future perspectives

M Schouten, S Dalle, D Mantini, K Koppo - Frontiers in Pharmacology, 2024 - frontiersin.org
Cannabidiol (CBD) is a naturally occurring non-psychoactive cannabinoid found in
Cannabis sativa, commonly known as cannabis or hemp. Although currently available CBD …

Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts

G Mick, P Douek - Pain and Therapy, 2024 - Springer
Interest in medical cannabis and cannabis-based medicinal products (CBMPs) has
increased greatly in recent years. Two cannabinoids are of principal importance; delta-9 …

Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021

J Geppert, J Lietzow, S Hessel-Pras, F Kirsch… - BMC public health, 2023 - Springer
Background Cannabidiol (CBD), a non-intoxicating substance of Cannabis sativa L., is
gaining consumer attention. Yet, legal regulations in the EU are complex and questions of …

[HTML][HTML] Subchronic oral toxicity assessment of a cannabis extract

MJ Tallon, R Child - Regulatory Toxicology and Pharmacology, 2023 - Elsevier
Cannabidiol (CBD) is present in Cannabis Sativa L. and has been used in medicines and
foods to deliver beneficial health effects. Despite this, research on CBD safety utilising …

Therapeutic use and other reasons to consume cannabidiol: insight from the French and Italian contexts

D Fortin, V Di Beo, P Carrieri, T Barré - Journal of Psychoactive …, 2023 - Taylor & Francis
Cannabidiol (CBD) has a wide spectrum of potential therapeutic use and is growing in
popularity. However, there is a need to characterize users, as associated benefits and risks …

Study of the relationship between psychoactive substance use and pain in cancer patients and cancer survivors: A French nationwide cross‐sectional study

C Ragusa, B Pereira… - International Journal of …, 2024 - Wiley Online Library
Pain is a prevalent symptom among cancer patients and survivors. Psychoactive substance
use (PSU) is associated with both the presence and severity of pain. However, little is known …

A multi-market comparison of composition, formulation, and label content of CBD e-liquids

J Hoeng, DARS Latino, WK Schlage, A Mazurov… - iScience, 2024 - cell.com
The prevalence of electronically vaporized cannabidiol (CBD) use is rising in many
countries. However, few regulatory frameworks exist for inhaled CBD, and this lack of …

[HTML][HTML] What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland

A Granville, J Grigg, M Kowalski, E Sevigny… - International Journal of …, 2024 - Elsevier
Background A market for cannabis with low levels (LT) of Tetrahydrocannabinol (THC) has
recently emerged in Europe alongside an ongoing trend of domestic cannabis cultivation …

Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults

T Barré, E Lahaie, V Di Beo, P Carrieri… - Drug and alcohol …, 2024 - Wiley Online Library
Introduction Cannabidiol (CBD) is a non‐intoxicating cannabis compound found in diverse
commercial products worldwide. However, its use may not be fully harmless. Accordingly, it …